News and blogs
340 results found.
Tom Youngs speaks publicly about his late wife, Tiff, as Will Findlay takes on new challenge
Former British and Irish Lions player, ex-England hooker and Leicester Tigers club captain Tom Youngs has spoken publicly for the first time about his wife Tiffany, sadly passed away to blood cancer in 2022.
Evusheld decision leaves members of blood cancer community disappointed
Today (16 February) NICE has deemed that there’s not enough evidence to say Evusheld is clinically effective against COVID-19 in the UK. NICE also said it is developing a new review process to update recommendations on the cost-effectiveness of COVID-19 treatments, so they can be made available more quickly if they show promise against new variants and are found to be cost-effective.
My priorities as chief executive of Blood Cancer UK
Helen gives her thoughts on her new role as Chief Executive of Blood Cancer UK.
World Cancer Day: Over 50% of UK adults can’t name a single symptom
This Saturday 4th Feb is #WorldCancerDay and we want you to help us shine a light on blood cancer. Why? Because despite being the fifth most common cancer, over 50% of UK adults can’t name a single symptom. Here's how you can get involved...
Blood cancer and travel: your guide
Tips for going on holiday when you have blood cancer, from symptoms and side effects, to packing medication and avoiding infections.
Tips on keeping safe in the sun
Clinical Nurse Specialist Jodie Nightingill gives her tips for enjoying the sunshine safely if you have blood cancer.
Blood Cancer UK disappointed by the Government’s ‘Major Conditions Strategy’
The Government’s Department of Health and Social Care announced a new UK wide ‘Major Conditions Strategy’, which they say will try to alleviate pressure on the health system. In 2022, the UK government had promised a 10-year cancer plan, however this new Major Conditions Strategy will now supersede this.
Blood cancer therapy to become routinely available for third line use on NHS
Today (Thursday 26 January), a review from National Institute for Health and Care Excellence (NICE) has deemed the blood cancer CAR-T therapy, axicabtagene ciloleucel (Yescarta), cost effective for routine use on the NHS in England.
Helen Rowntree appointed Blood Cancer UK’s chief executive
Blood Cancer UK has announced Helen Rowntree as its new permanent chief executive.
How we’re planning to make people more aware of blood cancer
Why do people diagnosed with blood cancer often leave with less knowledge of their condition compared to other cancers? We're tackling that question and outlining what we can do to raise the profile of blood cancer as a health condition.
Blood Cancer UK funding led to understanding the origins of childhood leukaemia in twins
New research has shed light on the origins on a type of blood cancer – childhood acute lymphoblastic leukaemia – and how it develops in children.
New ‘universal approach’ therapy for leukaemia shows promise during world-first trial
Blood Cancer UK was proud to fund the lab studies that directly led to this life-changing trial which could broaden the number of people who benefit from this type of therapy in future.
Paxlovid rebound: what we know
Paxlovid is the most commonly prescribed treatment for people with severe immunosuppression who test positive for covid-19. We look at the phenomenon called Paxlovid rebound and what it might mean for the future of Paxlovid treatment.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
New campaign launches for the forgotten 500,000 families
Patient groups, charities and clinicians unite to raise awareness of half a million vulnerable people, many of whose lives have never returned to normal after Covid-19 lockdown. The campaign is calling for the Government to reverse its decision and immediately roll out Evusheld for the immunosuppressed.
Health inequalities: how does stress change our bodies?
You might not have heard of "allostatic load" before, but scientists are learning more and more about how chronic stress adds to the ‘wear and tear’ on our bodies, the way it differs between ethnicities and leads to health inequality.
Sidney Farber - The Father of Modern Chemotherapy
Dr Sidney Farber was an American paediatric pathologist. He discovered the role folic acid played in the creation of leukaemia cells and achieved the first clinical remission of leukaemia in children by using a chemical anti agent.
Chief Executive Gemma Peters announces her departure
We are sad to announce that our chief executive, Gemma Peters, will be leaving Blood Cancer UK.
Celebrating September
For Blood Cancer Awareness Month, Jonathan shares his story in memory of his dad Ian whose MGUS developed into Acute Myeloid Leukaemia. Ian sadly died in May 2022; just 8 weeks after his diagnosis.
Remembering Her Majesty the Queen
